These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 17935635)
1. Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression. Murph M; Mills GB Expert Rev Mol Med; 2007 Oct; 9(28):1-18. PubMed ID: 17935635 [TBL] [Abstract][Full Text] [Related]
2. Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer. Peyruchaud O Anticancer Agents Med Chem; 2009 May; 9(4):381-91. PubMed ID: 19442039 [TBL] [Abstract][Full Text] [Related]
3. Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer. Murph M; Tanaka T; Liu S; Mills GB Clin Cancer Res; 2006 Nov; 12(22):6598-602. PubMed ID: 17121877 [TBL] [Abstract][Full Text] [Related]
4. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance. Selvam SP; Ogretmen B Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649 [TBL] [Abstract][Full Text] [Related]
5. Effects of LPA and S1P on the nervous system and implications for their involvement in disease. Herr DR; Chun J Curr Drug Targets; 2007 Jan; 8(1):155-67. PubMed ID: 17266539 [TBL] [Abstract][Full Text] [Related]
6. Different signaling pathway between sphingosine-1-phosphate and lysophosphatidic acid in Xenopus oocytes: functional coupling of the sphingosine-1-phosphate receptor to PLC-xbeta in Xenopus oocytes. Noh SJ; Kim MJ; Shim S; Han JK J Cell Physiol; 1998 Aug; 176(2):412-23. PubMed ID: 9648929 [TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy? Dai L; Xia P; Di W Cancer Invest; 2014 Mar; 32(3):71-80. PubMed ID: 24499107 [TBL] [Abstract][Full Text] [Related]
8. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Sorensen SD; Nicole O; Peavy RD; Montoya LM; Lee CJ; Murphy TJ; Traynelis SF; Hepler JR Mol Pharmacol; 2003 Nov; 64(5):1199-209. PubMed ID: 14573770 [TBL] [Abstract][Full Text] [Related]
10. Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate. Dolezalova H; Shankar G; Huang MC; Bikle DD; Goetzl EJ J Cell Biochem; 2003 Mar; 88(4):732-43. PubMed ID: 12577307 [TBL] [Abstract][Full Text] [Related]
11. A clean-up technology for the simultaneous determination of lysophosphatidic acid and sphingosine-1-phosphate by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using a phosphate-capture molecule, Phos-tag. Morishige J; Urikura M; Takagi H; Hirano K; Koike T; Tanaka T; Satouchi K Rapid Commun Mass Spectrom; 2010 Apr; 24(7):1075-84. PubMed ID: 20213695 [TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. Goetzl EJ; Kong Y; Mei B J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477 [TBL] [Abstract][Full Text] [Related]
13. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Siess W Biochim Biophys Acta; 2002 May; 1582(1-3):204-15. PubMed ID: 12069830 [TBL] [Abstract][Full Text] [Related]
14. Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis. Pyne NJ; Dubois G; Pyne S Biochim Biophys Acta; 2013 Jan; 1831(1):228-38. PubMed ID: 22801038 [TBL] [Abstract][Full Text] [Related]